This study characterizes the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection detected on polymerase chain reaction (PCR) screening of a large homeless shelter population in Boston prompted by an outbreak of COVID-19 cases among shelter residents.
Objective
The objective of the current study was to examine the feasibility of
telemedicine vs. telephone for the delivery of a multidisciplinary weekly
family based behavioral group intervention to treat pediatric obesity
delivered to families living in rural areas using a randomized controlled
trial methodology.
Methods
103 rural children and their families were recruited. Feasibility
measures included participant satisfaction, session attendance and
retention. Treatment outcome measures included child BMIz, Parent BMI,
24-hour dietary recalls, accelerometer data, Child Behavior Checklist and
the Behavioral Pediatrics Feeding Assessment Scale.
Results
Participants were highly satisfied with the intervention both via
telemedicine and via telephone. Completion rates were much higher than for
other pediatric obesity intervention programs, and both methodologies were
highly feasible. There were no differences in telemedicine and telephone
groups on primary outcomes.
Conclusion
Both telemedicine and telephone intervention appear to be feasible
and acceptable methods of delivering pediatric obesity treatment to rural
children.
Women and patients who reported increased treatment satisfaction and reduced burden to others were more adherent to oral chemotherapy. Interventions that help patients improve communication with clinicians and reduce burden may optimize oral chemotherapy adherence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.